Skip to main content
Premium Trial:

Request an Annual Quote

Monsanto Pledges Additional $3M to Fund Corn Rootworm Research

Premium

Monsanto said this week that it has set aside an additional $3 million to fund academic research into the corn rootworm, a key agriculture pest that attacks the roots of corn crops.

The funding is part of Monsanto's Corn Rootworm Knowledge Research program, which was launched in 2012 by the company and promised up to $3 million to fund three-year awards of up to $250,000 a year for academic researchers.

Among the previous recipients is Bryony Bonning, an Iowa State University investigator exploring the use of RNAi to control corn rootworms.

Monsanto has a number of internal programs aiming to use the gene-silencing technology, including ones focused on corn rootworm.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.